Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerated Biological Aging Increases the Risk of Head and Neck Cancer: Insights From Genetic Instruments of Epigenetic Clocks.

Molecular carcinogenesis·2026
Same author

Exploring the Contribution of Interleukin-12A Genetic Polymorphisms to Pterygium Risk.

In vivo (Athens, Greece)·2026
Same author

Insights into Matrix Metalloproteinase-2 Genotypes, Smoking, Alcohol Drinking, Hypertension and Renal Cell Carcinoma in Taiwan.

Anticancer research·2026
Same author

8-Gingerol Mitigates MPP<sup>+</sup>-Induced α-Synuclein Aggregation and NLRP3 Inflammasome Activation by Inducing the Insulin Signaling Pathway in SH-SY5Y Cells.

Neurochemical research·2026
Same author

MMP-9 Genotypes Serve as Oral Cancer Predictive Marker for Smokers.

Anticancer research·2026
Same author

Recurrent Sigmoid Volvulus in a Young Female With Ulcerative Colitis: A Case Report and Review of the Literature.

Cureus·2026
Same journal

Upregulated Circular RNAs in Gastric Cancer: Target Identification and Tools for Therapeutic Intervention.

Cancer genomics & proteomics·2026
Same journal

Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating <i>YAP1</i> rs1894116 and Focal Adhesion Signaling.

Cancer genomics & proteomics·2026
Same journal

Beta-site Amyloid Precursor Protein Cleaving Enzyme 1 Overexpression Abrogates ST6GAL1 Mediated Rectal Cancer Chemoradiation Resistance.

Cancer genomics & proteomics·2026
Same journal

Glucose and Glutamine Define Independent Activation-Braking Metabolic States in Triple Negative Breast Cancer Cells.

Cancer genomics & proteomics·2026
Same journal

Transcriptomic Profiling Identifies Higher DOT1L Expression as a Candidate Biomarker for a Positive Response to Gemcitabine in Cholangiocarcinoma.

Cancer genomics & proteomics·2026
Same journal

IL1B-Expressing Exhausted CD4<sup>+</sup> T Cells Are Associated With Disease Aggressiveness in Glioblastoma.

Cancer genomics & proteomics·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Genetic Insights into Interleukin-13 Polymorphisms in Colorectal Cancer Risk and Progression.

Te-Cheng Yueh1,2,3, Tao-Wei Ke4, Jiaqi Wang5,6

  • 1National Defense Medical University, Taipei, Taiwan, R.O.C.

Cancer Genomics & Proteomics
|June 29, 2026
PubMed
Summary
This summary is machine-generated.

Interleukin-13 (IL-13) gene variations rs1800925 and rs20541 do not influence colorectal cancer (CRC) risk but may indicate more aggressive disease. These findings suggest IL-13 polymorphisms could help stratify CRC severity.

Keywords:
Colorectal cancergenotypeinterleukin-13metastasispolymorphismstage

Related Experiment Videos

Last Updated: Jul 1, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Colorectal cancer (CRC) presents a significant global health challenge, with rising incidence and mortality rates.
  • Genetic factors and inflammatory pathways, including cytokine signaling, are crucial in CRC development.
  • The role of Interleukin-13 (IL-13) polymorphisms, specifically rs1800925 and rs20541, in CRC pathogenesis requires further clarification.

Purpose of the Study:

  • To investigate the association between IL-13 polymorphisms (rs1800925 and rs20541) and colorectal cancer (CRC) susceptibility.
  • To explore the correlation of these IL-13 polymorphisms with CRC clinicopathological features and disease aggressiveness.

Main Methods:

  • A hospital-based case-control study in Taiwan included 362 CRC patients and 362 matched controls.
  • Genotyping of IL-13 rs1800925 and rs20541 was performed using polymerase chain reaction-restriction fragment length polymorphism.
  • Statistical analysis using odds ratios (ORs) and 95% confidence intervals (CIs) assessed associations with CRC risk and clinicopathological parameters.

Main Results:

  • No significant association was found between IL-13 rs1800925 or rs20541 polymorphisms and overall CRC susceptibility.
  • The rs1800925 CT+TT genotypes were linked to an increased risk of distant metastasis at diagnosis (OR=2.12).
  • The rs20541 AG+AA genotypes were associated with advanced stage (OR=1.50) and metastatic disease (OR=2.16) at diagnosis.

Conclusions:

  • IL-13 rs1800925 and rs20541 polymorphisms are not linked to CRC susceptibility.
  • These polymorphisms may correlate with clinicopathological aggressiveness in CRC patients.
  • IL-13 variants could potentially aid in stratifying CRC severity, particularly within the Taiwanese population.